NAMSNewAmsterdam Pharma Company N.V.

$27.41

Is it safe?

Can NAMS take a bad year?

The deepest fall in NAMS's price history on file is −66%; it is −34% below its high today.

−66%

Worst drawdown on file · −34% today

Cash runway
4.5 years

Cash runway · burning $36M a quarter at the current rate

Annualised volatility
63%

Annualised volatility · three times the market's own swing

Details
Cash and short-term investments
$636M
EBITDA, trailing twelve months
−$215M
Operating profit, trailing twelve months
−$215M
Annualised volatilitytwo years of daily moves
63%
Worst drawdown on file
−66%
Below its 52-week high
−34%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.